CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Summary

This phase II trial is studying how well CCI-779 works in treating patients with relapsed or refractory chronic lymphocytic leukemia. Drugs used in chemotherapy, such as CCI-779, work in different ways to stop cancer cells from dividing so they stop growing or die

Timeline

Start

2004-05

Primary completion

2005-08

Completion

—

Drugs

Indications